Incorporating Health Equity Into COVID-19 Reopening Plans: Policy Experimentation in California

Incorporating Health Equity Into COVID-19 Reopening Plans: Policy Experimentation in California

Michelle Mello evaluates the benefits and challenges of California's novel health equity focus in its reopening efforts and outlines recommendations for other U.S. states to address disparities in their reopening plans.
California Gov. Gavin Newsom celebrates the state's reopening after COVID-19 pandemic.. Getty Images

California has focused on health equity in the state’s COVID-19 reopening plan. The Blueprint for a Safer Economy assigns each of California’s 58 counties into one of four tiers based on two metrics: test positivity rate and adjusted case rate. To advance to the next less-restrictive tier, counties must meet that tier’s test positivity and adjusted case rate thresholds. In addition, counties must have a plan for targeted investments within disadvantaged communities, and counties with more than 106 000 residents must meet an equity metric.

California's explicit incorporation of health equity into its reopening plan underscores the interrelated fate of its residents during the COVID-19 pandemic and creates incentives for action.

In this article published in the American Journal of Public Health, SHP's Michelle Mello, a professor of medicine and professor of law at Stanford Law School, and colleagues evaluates the benefits and challenges of this novel health equity focus, and outlines recommendations for other US states to address disparities in their reopening plans.

Read Full Article

Michelle Mello

Michelle Mello

Professor of Medicine and Professor of Law
Researchers issues at the intersection of law, ethics and health policy.
Profile

Read More

A health-care worker holds up a COVID-19 vaccine
Commentary

Choices in a Crisis — Individual Preferences among COVID Vaccines

Now that a third COVID-19 vaccine has been given emergency-use authorization, Michelle Mello and colleagues ask whether individuals should be able to choose which vaccine they receive.
cover link Choices in a Crisis — Individual Preferences among COVID Vaccines
David Studdert and Michelle Mello of Stanford University
News

Critical Legal and Policy Solutions to the COVID-19 Pandemic

Stanford Law School health law experts Michelle Mello and David Studdert, also professors of medicine at Stanford Health Policy, share insights into the government’s response and offer hope that science —and unbiased scholarly research — can help curtail the rising toll of COVID-19.
cover link Critical Legal and Policy Solutions to the COVID-19 Pandemic
Commuters wear protective masks
Commentary

The Uncertain Impact of Accelerating Science

The urgency of the coronavirus pandemic has led to enormous research efforts and some shortcuts. Michelle Mello, a professor of medicine and law, and David Magnus, a professor of medicine and biomedical ethnics, write in this Scientific American commentary that the scientific surge to understand COVID-19 is inspiring — but has led to some ethical dilemmas.
cover link The Uncertain Impact of Accelerating Science